Australia - engelsk - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - clopidogrel besilate, quantity: 111.86 mg (equivalent: clopidogrel, qty 75 mg) - tablet, film coated - excipient ingredients: mannitol; microcrystalline cellulose; colloidal anhydrous silica; stearic acid; hypromellose; titanium dioxide; iron oxide red - prevention of vascular ischaemia associated with atherothrombotic events (myocardial infarction, stroke and vascular death) in patients with a history of symptomatic atherosclerotic disease.,acute coronary syndrome,clopidogrel is indicated in combination with aspirin for patients with,-unstable angina or non-st-elevation myocardial infarction in order to prevent early and long-termatherothrombotic events (myocardial infarction, stroke, vascular death or refractory ischaemia). clopidogrel is indicated for the treatment of acute coronary syndrome whether or not patients undergo cardiac revascularisation (surgical or pci, with or without stent).,- st-segment elevation acute myocardial infarction in order to prevent atherothrombotic events. in thispopulation, clopidogrel has been shown to reduce the rate of death from any cause and the rate of a combined endpoint of death, re-infarction or stroke in medically treated patients eligible for thrombolytic therapy.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - clopidogrel besilate, quantity: 111.86 mg (equivalent: clopidogrel, qty 75 mg) - tablet, film coated - excipient ingredients: lactose; microcrystalline cellulose; crospovidone; glyceryl behenate; purified talc; titanium dioxide; iron oxide red; polyvinyl alcohol; macrogol 3350; lecithin - prevention of vascular ischaemia associated with atherothrombotic events (myocardial infarction, stroke and vascular death) in patients with a history of symptomatic atherosclerotic disease.,acute coronary syndrome,clopidogrel gh is indicated in combination with aspirin for patients with:,- unstable angina or non-st-elevation myocardial infarction in order to prevent early and long-term atherothrombotic events (myocardial infarction, stroke, vascular death or refractory ischaemia). clopidogrel gh is indicated for the treatment of acute coronary syndrome whether or not patients undergo cardiac revascularisation (surgical or pci, with or without stent),- st-segment elevation acute myocardial infarction in order to prevent atherothrombotic events. in this population, clopidogrel has been shown to reduce the rate of death from any cause and the rate of a combined endpoint of death, re-infarction or stroke in medically treated patients eligible for thrombolytic therapy.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - clopidogrel besilate, quantity: 111.86 mg (equivalent: clopidogrel, qty 75 mg) - tablet, film coated - excipient ingredients: lactose; microcrystalline cellulose; crospovidone; glyceryl behenate; purified talc; titanium dioxide; iron oxide red; polyvinyl alcohol; macrogol 3350; lecithin - prevention of vascular ischaemia associated with atherothrombotic events (myocardial infarction, stroke and vascular death) in patients with a history of symptomatic atherosclerotic disease.,acute coronary syndrome,clopidogrel gh is indicated in combination with aspirin for patients with:,- unstable angina or non-st-elevation myocardial infarction in order to prevent early and long-term atherothrombotic events (myocardial infarction, stroke, vascular death or refractory ischaemia). clopidogrel gh is indicated for the treatment of acute coronary syndrome whether or not patients undergo cardiac revascularisation (surgical or pci, with or without stent),-st-segment elevation acute myocardial infarction in order to prevent atherothrombotic events. in this population, clopidogrel has been shown to reduce the rate of death from any cause and the rate of a combined endpoint of death, re-infarction or stroke in medically treated patients eligible for thrombolytic therapy.

Canada - fransk - Health Canada

apotex inc - clopidogrel (bisulfate de clopidogrel) - comprimé - 75mg - clopidogrel (bisulfate de clopidogrel) 75mg - platelet aggregation inhibitors

Canada - fransk - Health Canada

teva canada limited - clopidogrel (bisulfate de clopidogrel) - comprimé - 75mg - clopidogrel (bisulfate de clopidogrel) 75mg - platelet aggregation inhibitors

Canada - fransk - Health Canada

teva canada limited - clopidogrel (bisulfate de clopidogrel) - comprimé - 300mg - clopidogrel (bisulfate de clopidogrel) 300mg - platelet aggregation inhibitors

Canada - fransk - Health Canada

apotex inc - clopidogrel (bisulfate de clopidogrel) - comprimé - 300mg - clopidogrel (bisulfate de clopidogrel) 300mg - platelet aggregation inhibitors

Canada - fransk - Health Canada

marcan pharmaceuticals inc - clopidogrel (bisulfate de clopidogrel) - comprimé - 75mg - clopidogrel (bisulfate de clopidogrel) 75mg - platelet aggregation inhibitors

Canada - fransk - Health Canada

marcan pharmaceuticals inc - clopidogrel (bisulfate de clopidogrel) - comprimé - 300mg - clopidogrel (bisulfate de clopidogrel) 300mg - platelet aggregation inhibitors

Canada - fransk - Health Canada

marcan pharmaceuticals inc - clopidogrel (bisulfate de clopidogrel) - comprimé - 300mg - clopidogrel (bisulfate de clopidogrel) 300mg - platelet aggregation inhibitors